file1,
file2, etc. all in the same folder or directory;
first, locate one of the files with the [Browse...] button. Then alter the
file path in the box above to include '*' character (eg. file*).
Wildcard '?' to blanket only one character works too.| Historiographs |
Grand Totals: LCS 7398, GCS 21737, CR 38784 Collection span: 1977 - 2012 | |
| Word(i) List (2518) Word count: 12056, All words count: 16977 | ||
| # | Word | Recs | TLCS | TGCS |
|---|---|---|---|---|
| 801 | REACTION-BASED | 2 | 3 | 33 |
| 802 | REPERTOIRE | 1 | 18 | 33 |
| 803 | SPONTANEOUS | 6 | 12 | 33 |
| 804 | ANSWERS | 1 | 21 | 32 |
| 805 | CD154 | 2 | 1 | 32 |
| 806 | FAILS | 2 | 15 | 32 |
| 807 | NEONATALLY | 2 | 15 | 32 |
| 808 | PRIMATES | 5 | 7 | 32 |
| 809 | QUESTIONS | 1 | 21 | 32 |
| 810 | SINGLE | 6 | 2 | 32 |
| 811 | ADULTS | 1 | 28 | 31 |
| 812 | CANCERS | 2 | 4 | 31 |
| 813 | CONNECTIVE | 1 | 29 | 31 |
| 814 | CONSIDERATIONS | 1 | 2 | 31 |
| 815 | GLANDS | 4 | 26 | 31 |
| 816 | HAPLO-IDENTICAL | 3 | 28 | 31 |
| 817 | HLA-DEPENDENT | 1 | 20 | 31 |
| 818 | IMMUNOFLUORESCENCE | 3 | 29 | 31 |
| 819 | KIDNEY-TRANSPLANTATION | 1 | 20 | 31 |
| 820 | MOLECULES | 4 | 14 | 31 |
| 821 | MONOCYTE | 2 | 28 | 31 |
| 822 | MYELOID | 5 | 8 | 31 |
| 823 | SALIVARY | 4 | 26 | 31 |
| 824 | SHEEP | 2 | 0 | 31 |
| 825 | SYSTEM | 3 | 1 | 31 |
| 826 | UNDERLIE | 1 | 20 | 31 |
| 827 | VENOOCCLUSIVE | 1 | 2 | 31 |
| 828 | ADENOMAS | 1 | 28 | 30 |
| 829 | BRONCHIOLITIS | 3 | 1 | 30 |
| 830 | CYCLOSPORINE | 3 | 3 | 30 |
| # | Word | Recs | TLCS | TGCS |
| 831 | DIABETOGENIC | 3 | 14 | 30 |
| 832 | DQ2 | 3 | 14 | 30 |
| 833 | DQ8 | 3 | 14 | 30 |
| 834 | EPITOPE | 5 | 20 | 30 |
| 835 | FOLLICULAR | 1 | 28 | 30 |
| 836 | LABIAL | 2 | 25 | 30 |
| 837 | NON-TRANSMITTED | 3 | 14 | 30 |
| 838 | OBLITERANS | 3 | 1 | 30 |
| 839 | PARTUM | 3 | 14 | 30 |
| 840 | POLYMORPHISMS | 5 | 10 | 30 |
| 841 | POST | 3 | 14 | 30 |
| 842 | PREVALENT | 1 | 28 | 30 |
| 843 | SHARED | 5 | 20 | 30 |
| 844 | THYROID-INFILTRATING | 1 | 28 | 30 |
| 845 | TYPES | 1 | 26 | 30 |
| 846 | Y-CHROMOSOMAL | 1 | 28 | 30 |
| 847 | ALLOIMMUNITY | 3 | 9 | 29 |
| 848 | BMT | 1 | 0 | 29 |
| 849 | COLOR | 1 | 0 | 29 |
| 850 | COURSE | 4 | 11 | 29 |
| 851 | DEPLETED | 5 | 11 | 29 |
| 852 | DERIVES | 1 | 21 | 29 |
| 853 | DUAL | 1 | 0 | 29 |
| 854 | FATE | 6 | 7 | 29 |
| 855 | HAND | 2 | 2 | 29 |
| 856 | INTERPHASE | 1 | 0 | 29 |
| 857 | LUNGS | 2 | 1 | 29 |
| 858 | NEOANGIOGENESIS | 1 | 21 | 29 |
| 859 | NON-T-CELL | 5 | 11 | 29 |
| 860 | PARTLY | 1 | 21 | 29 |
| # | Word | Recs | TLCS | TGCS |
| 861 | PRIMER | 2 | 8 | 29 |
| 862 | REGULARLY | 1 | 7 | 29 |
| 863 | SECOND | 7 | 3 | 29 |
| 864 | TUBULAR | 1 | 7 | 29 |
| 865 | UTILIZING | 1 | 0 | 29 |
| 866 | ALLOPEPTIDES | 1 | 4 | 28 |
| 867 | ANTIBODY-POSITIVE | 1 | 1 | 28 |
| 868 | CLUSTER | 1 | 0 | 28 |
| 869 | DEPENDENCE | 1 | 9 | 28 |
| 870 | DEVELOPING | 1 | 1 | 28 |
| 871 | INSURGENT | 1 | 21 | 28 |
| 872 | LEVOTHYROXINE | 1 | 1 | 28 |
| 873 | MICROCHIMERISM-ASSOCIATED | 1 | 9 | 28 |
| 874 | NONRESPONSIVENESS | 1 | 4 | 28 |
| 875 | PEROXIDASE | 1 | 1 | 28 |
| 876 | PIVOTAL | 1 | 9 | 28 |
| 877 | PREVENT | 4 | 2 | 28 |
| 878 | PROTECTOR | 1 | 21 | 28 |
| 879 | RECRUITS | 2 | 6 | 28 |
| 880 | SEQUENTIAL | 4 | 19 | 28 |
| 881 | SWINE | 5 | 3 | 28 |
| 882 | TECHNOLOGIES | 1 | 1 | 28 |
| 883 | ADJUNCT | 1 | 12 | 27 |
| 884 | BETWIXT | 1 | 4 | 27 |
| 885 | CAUTIONARY | 1 | 23 | 27 |
| 886 | COMPARTMENTALIZATION | 1 | 12 | 27 |
| 887 | CONDITIONED | 1 | 1 | 27 |
| 888 | DELAYED | 1 | 0 | 27 |
| 889 | DEPLETION | 1 | 0 | 27 |
| 890 | FEMORAL | 1 | 1 | 27 |
| # | Word | Recs | TLCS | TGCS |
| 891 | IMMUNOLABELING | 1 | 21 | 27 |
| 892 | INCREASES | 2 | 12 | 27 |
| 893 | INTERFERING | 1 | 3 | 27 |
| 894 | JAGGED2-EXPRESSING | 1 | 0 | 27 |
| 895 | MARKERS | 3 | 24 | 27 |
| 896 | METHODOLOGICAL | 2 | 22 | 27 |
| 897 | MOBILIZED | 1 | 0 | 27 |
| 898 | MONOCHORIONIC | 1 | 2 | 27 |
| 899 | MULTIPOTENT | 2 | 13 | 27 |
| 900 | NATURALLY | 3 | 19 | 27 |
| 901 | NON-HISTOCOMPATIBILITY | 1 | 3 | 27 |
| 902 | NONLYMPHOID | 1 | 12 | 27 |
| 903 | NOTCH | 1 | 0 | 27 |
| 904 | PARADIGM | 4 | 8 | 27 |
| 905 | PCR-SSP | 3 | 23 | 27 |
| 906 | PERIPHERY | 2 | 0 | 27 |
| 907 | PRAGOCYTIC | 1 | 0 | 27 |
| 908 | RETICULOENDOTHELIAL | 1 | 0 | 27 |
| 909 | SENSITIZED | 4 | 10 | 27 |
| 910 | SIGNALING | 1 | 0 | 27 |
| 911 | SURGICAL | 2 | 1 | 27 |
| 912 | TALE | 1 | 23 | 27 |
| 913 | TECHNOLOGY | 1 | 2 | 27 |
| 914 | THALASSEMIA | 4 | 1 | 27 |
| 915 | WHOLE-ORGAN | 1 | 3 | 27 |
| 916 | WIDE | 1 | 3 | 27 |
| 917 | ALLOIMMUNE | 2 | 2 | 26 |
| 918 | ASSAY | 5 | 2 | 26 |
| 919 | BOTRYLLUS | 1 | 0 | 26 |
| 920 | COHORT | 4 | 4 | 26 |
| # | Word | Recs | TLCS | TGCS |
| 921 | COLONIAL | 1 | 0 | 26 |
| 922 | CYTOABLATION | 1 | 4 | 26 |
| 923 | DISEASED | 2 | 23 | 26 |
| 924 | FROZEN | 1 | 3 | 26 |
| 925 | GASTROINTESTINAL | 2 | 1 | 26 |
| 926 | HLA-IDENTICAL | 3 | 4 | 26 |
| 927 | INDEFINITE | 1 | 4 | 26 |
| 928 | LOCALIZED | 2 | 12 | 26 |
| 929 | METHOD | 8 | 1 | 26 |
| 930 | MORULA | 1 | 0 | 26 |
| 931 | NON-HUMAN | 3 | 4 | 26 |
| 932 | PCR-BASED | 3 | 20 | 26 |
| 933 | PERSPECTIVES | 2 | 9 | 26 |
| 934 | PLANUS | 4 | 23 | 26 |
| 935 | SCHLOSSERI | 1 | 0 | 26 |
| 936 | TRANSGENIC | 4 | 5 | 26 |
| 937 | UROCHORDATE | 1 | 0 | 26 |
| 938 | WHOLE-BLOOD | 1 | 3 | 26 |
| 939 | ANTI-D | 2 | 0 | 25 |
| 940 | CHANGING | 1 | 5 | 25 |
| 941 | COMPLICATION | 2 | 13 | 25 |
| 942 | DISCORDANT | 4 | 11 | 25 |
| 943 | FK506 | 2 | 0 | 25 |
| 944 | FOETAL | 4 | 6 | 25 |
| 945 | HY-SPECIFIC | 1 | 8 | 25 |
| 946 | HYPOTHESIS | 2 | 5 | 25 |
| 947 | IMPROVES | 3 | 0 | 25 |
| 948 | INFECTIONS | 2 | 1 | 25 |
| 949 | LIGAND-MOBILIZED | 2 | 2 | 25 |
| 950 | PATHWAY | 2 | 2 | 25 |
| # | Word | Recs | TLCS | TGCS |
| 951 | PROLONG | 4 | 3 | 25 |
| 952 | PROPORTION | 1 | 8 | 25 |
| 953 | PROTECTIVE | 3 | 12 | 25 |
| 954 | SELF | 2 | 5 | 25 |
| 955 | SLE | 4 | 23 | 25 |
| 956 | TNF | 2 | 1 | 25 |
| 957 | TWO-WAY | 2 | 4 | 25 |
| 958 | VITRO | 3 | 2 | 25 |
| 959 | ALLERGY | 1 | 0 | 24 |
| 960 | HIV-INFECTED | 1 | 16 | 24 |
| 961 | INCIDENCE | 6 | 1 | 24 |
| 962 | MATCHED | 3 | 6 | 24 |
| 963 | MEASUREMENT | 3 | 15 | 24 |
| 964 | NUT | 1 | 0 | 24 |
| 965 | PASSIVE | 1 | 0 | 24 |
| 966 | RECENT | 3 | 3 | 24 |
| 967 | REFRACTORY | 3 | 10 | 24 |
| 968 | UNMANIPULATED | 5 | 6 | 24 |
| 969 | ALLOREACTIVE | 2 | 2 | 23 |
| 970 | CHANGES | 4 | 5 | 23 |
| 971 | INFANTILE | 3 | 4 | 23 |
| 972 | INJURED | 3 | 14 | 23 |
| 973 | SCLEROSUS | 6 | 2 | 23 |
| 974 | TRIPLETS | 3 | 11 | 23 |
| 975 | UNDERSTANDING | 3 | 0 | 23 |
| 976 | ALLOSPECIFIC | 1 | 0 | 22 |
| 977 | CULTURED | 1 | 0 | 22 |
| 978 | CYNOMOLGUS | 2 | 0 | 22 |
| 979 | EMPHASIS | 1 | 6 | 22 |
| 980 | EXPANDING | 2 | 14 | 22 |
| # | Word | Recs | TLCS | TGCS |
| 981 | EXTRACARDIAC | 1 | 0 | 22 |
| 982 | FIBROBLASTS | 1 | 0 | 22 |
| 983 | FREQUENTLY | 1 | 0 | 22 |
| 984 | GRAVID | 1 | 6 | 22 |
| 985 | INTERACTIONS | 3 | 6 | 22 |
| 986 | INTERFERE | 2 | 3 | 22 |
| 987 | MARROW-AUGMENTED | 1 | 4 | 22 |
| 988 | NEVER | 2 | 20 | 22 |
| 989 | NONMYELOABLATED | 1 | 8 | 22 |
| 990 | PROGENY | 1 | 0 | 22 |
| 991 | RAYNAUD | 1 | 2 | 22 |
| 992 | REGRESSION | 1 | 22 | 22 |
| 993 | SEVERELY | 1 | 13 | 22 |
| 994 | STROMA | 1 | 0 | 22 |
| 995 | TUMOR | 3 | 14 | 22 |
| 996 | UNFINISHED | 1 | 6 | 22 |
| 997 | AFFINITY-DEPENDENT | 1 | 13 | 21 |
| 998 | ALLOANTIBODY | 2 | 0 | 21 |
| 999 | ALTERATIONS | 2 | 13 | 21 |
| 1000 | DEBATE | 1 | 12 | 21 |